home / stock / anab / anab articles

ANAB Articles, AnaptysBio Inc.

Stock Information
Company Name: AnaptysBio Inc.
Stock Symbol: ANAB
Market: NASDAQ
Website: anaptysbio.com
Menu
ANAB ANAB Quote ANAB Short ANAB News ANAB Articles ANAB Message Board
Get ANAB Alerts

News, Short Squeeze, Breakout and More Instantly...
Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties | Benzinga

Anaptys to receive $50 million upfront cash payment from Sagard Healthcare Prior agreement amended to now expire once Sagard receives a capped pa...
Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates | Benzinga

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. Th...

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial resul...

Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose shar...
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers | Benzinga

Monday, AnaptysBio Inc (NASDAQ:ANAB) reported a fourth-quarter 2023 EPS of $(1.59), slightly better than the consensus of $(1.60). T...

Anaptys to Present at TD Cowen's 44th Annual Health Care Conference and 2024 AAD Annual Meeting | Benzinga

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innova...

Anaptys to Present at Guggenheim's 6th Annual Biotechnology Conference | Benzinga

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innova...
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of AnaptysBio, Inc. (NASDAQ: ANAB) and Encourages Investors to Contact the Firm | Benzinga

PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating AnaptysBio, Inc. (NASDAQ:ANAB) ("AnaptysBio"...

INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into AnaptysBio, Inc.; Urges AnaptysBio's Stockholders to Contact Abbott Cooper Regarding Their Legal Rights | Benzinga

STAMFORD, Conn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Abbott Cooper PLLC is investigating AnaptysBio, Inc. (NASDAQ:ANAB) ("AnaptysBio" or the "Comp...

Anaptys Announces Participation in November Investor Conferences | Benzinga

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering innova...
Next 10